Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Simon Fraser University

$24,550.00

Rapid electronic quantitation of stabilized salivary lysozyme, a biomarker for multiple human diseases

FY 2011-12

Summary
The 21st century challenge for rapid monitoring of disease markers in body fluids is to find a synergy between two kinds of technical innovation: first, a reliable and painless means for collecting and preserving relevant body fluids, such as saliva and tears, whose integrity can be maintained such that biomarkers within them can be reliably measured; and, second, development of rapid and versatile sensing methodologies that can be used at the point of care to generate a signal that is both easily read and easily transmitted to centres of disease control. Regarding the first need, DNA Genotek has pioneered a technology for preserving body fluids for genomic and potentially proteomic analysis. As for the second need, the Sen and Yu laboratories at Simon Fraser University have pioneered and patented the aptamer-based Deoxyribosensor (DORS) technology, which offers rapid, sensitive, and inexpensive electronic bioassays for detection and quantitation of disease biomarkers in body fluids. This collaboration between SFU And DNA Genotek proposes to develop synergy and compatibility between DNA Genotek's proprietary technology for body fluid collection and preservation; and the patented ""DORS"" biosensing technology from Simon Fraser University. Lysozyme, a multi-disease marker present in saliva, tears, and other body fluids will be the prototype test marker for developing the above synergy.
Program
Engage Grants Program
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
417919-2011
Name nom
Sen, Dipankar
Department département
Molecular Biology and Biochemistry
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
24550
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
508
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Polymers, rubber and plastics
Area of application fr
Polymères, caoutchouc et plastiques
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
1
Nb partie
1
Application title
Rapid electronic quantitation of stabilized salivary lysozyme, a biomarker for multiple human diseases
Keyword
NSERC
Application summary
The 21st century challenge for rapid monitoring of disease markers in body fluids is to find a synergy between two kinds of technical innovation: first, a reliable and painless means for collecting and preserving relevant body fluids, such as saliva and tears, whose integrity can be maintained such that biomarkers within them can be reliably measured; and, second, development of rapid and versatile sensing methodologies that can be used at the point of care to generate a signal that is both easily read and easily transmitted to centres of disease control. Regarding the first need, DNA Genotek has pioneered a technology for preserving body fluids for genomic and potentially proteomic analysis. As for the second need, the Sen and Yu laboratories at Simon Fraser University have pioneered and patented the aptamer-based Deoxyribosensor (DORS) technology, which offers rapid, sensitive, and inexpensive electronic bioassays for detection and quantitation of disease biomarkers in body fluids. This collaboration between SFU And DNA Genotek proposes to develop synergy and compatibility between DNA Genotek's proprietary technology for body fluid collection and preservation; and the patented ""DORS"" biosensing technology from Simon Fraser University. Lysozyme, a multi-disease marker present in saliva, tears, and other body fluids will be the prototype test marker for developing the above synergy.